Alector, LLC
NEWS
Alector, Inc. announced the addition of Kristine Yaffe, M.D., to the Company’s board of directors.
A list of the top 10 biotech IPOs from January to the end of June this year shows significant involvement in the Hong Stock exchange, with five companies based in China, and one, Frontage Holdings, operating in both the U.S. and China.
A summary of IPOs from companies in the biotech and pharma world since February 1, 2019.
The government shutdown threw a wrench into several biotech company’s plans for initial public offerings (IPOs). Although the government is only guaranteed to stay open until February 15, several biotechs are working to get their IPOs launched in that window. Here’s a look.
A summary of IPOs from companies in the biotech and pharma world since January 1, 2019.
South San Francisco-based Alector closed on a Series E financing worth $133 million. The money will be used to advance the company’s clinical programs and expand its discovery platform.
AbbVie announced a strategic collaboration with Alector to develop and commercialize drugs for ALZ’s disease and other neurodegenerative disorders.
JOBS
IN THE PRESS
